LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Actinium Pharmaceuticals Inc

Uždarymo kaina

1.81 8.38

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.62

Max

1.84

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-9.3M

-16M

Pelnas, tenkantis vienai akcijai

-0.51

Darbuotojai

31

EBITDA

-9.3M

-17M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+255.03% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-01

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2.2M

51M

Ankstesnė atidarymo kaina

-6.57

Ankstesnė uždarymo kaina

1.81

Actinium Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-06-05 20:45; UTC

Uždarbis

Broadcom 2Q Sales Climb on Booming AI Demand

2025-06-05 23:45; UTC

Rinkos pokalbiai

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

2025-06-05 23:44; UTC

Rinkos pokalbiai

Gold Edges Higher on Weak U.S. Data -- Market Talk

2025-06-05 23:30; UTC

Rinkos pokalbiai

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

2025-06-05 21:32; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-05 20:45; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:24; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Rev $15B >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Net $4.97B >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Adj EPS $1.58 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q EPS $1.03 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom Sees 3Q Rev $15.8B >AVGO

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

2025-06-05 19:22; UTC

Rinkos pokalbiai

Oil Futures Resume Upward Moves -- Market Talk

2025-06-05 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025-06-05 18:32; UTC

Rinkos pokalbiai

Gold Slips After Trump-Xi Call -- Market Talk

2025-06-05 18:26; UTC

Uždarbis

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

2025-06-05 18:06; UTC

Rinkos pokalbiai

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

2025-06-05 16:30; UTC

Įsigijimai, susijungimai, perėmimai

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

2025-06-05 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-05 16:18; UTC

Rinkos pokalbiai

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

2025-06-05 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-06-05 16:12; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-06-05 16:12; UTC

Rinkos pokalbiai

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

2025-06-05 16:03; UTC

Rinkos pokalbiai

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

2025-06-05 15:49; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Actinium Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

255.03% į viršų

12 mėnesių prognozė

Vidutinis 6 USD  255.03%

Aukščiausias 9 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Actinium Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.